financetom
Business
financetom
/
Business
/
T-mobile Us Insider Sold Shares Worth $375,209, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
T-mobile Us Insider Sold Shares Worth $375,209, According to a Recent SEC Filing
Mar 6, 2024 2:04 PM

04:56 PM EST, 03/06/2024 (MT Newswires) -- Callie R Field, President, Business Group, on March 04, 2024, sold 2,288 shares in T-mobile Us ( TMUS ) for $375,209. Following the Form 4 filing with the SEC, Field has control over a total of 108,399 shares of the company, with 108,399 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1283699/000128369924000038/xslF345X03/wk-form4_1709761941.xml

Price: 167.9, Change: +0.48, Percent Change: +0.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Katapult Holdings (KPLT) Shares Are Up 63% Today
Why Katapult Holdings (KPLT) Shares Are Up 63% Today
Jan 16, 2025
Katapult Holdings Inc ( KPLT ) shares are trading higher by 63% to $11.41 during Thursday’s session after the company reported $75.2 million in gross originations for the fourth quarter of 2024, up 11.3% year-over-year and surpassing its November forecast of 6-8% growth. What To Know: Katapult ( KPLT ) says this marks the ninth consecutive quarter of annual growth...
New Analysis of Omeros' Narsoplimab to Treat Complications From Stem Cell Transplant Support Results
New Analysis of Omeros' Narsoplimab to Treat Complications From Stem Cell Transplant Support Results
Jan 16, 2025
02:17 PM EST, 01/16/2025 (MT Newswires) -- Omeros ( OMER ) said Thursday that results from a statistical analysis of narsoplimab, its monoclonal antibody to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA, showed robustness of the previously reported primary endpoint analysis. The company said that newly completed sensitivity analyses confirm the survival benefit of narsoplimab in patients with...
Issuer Direct to Be Renamed ACCESS Newswire, Change Ticker to ACCS
Issuer Direct to Be Renamed ACCESS Newswire, Change Ticker to ACCS
Jan 16, 2025
02:18 PM EST, 01/16/2025 (MT Newswires) -- Issuer Direct ( ISDR ) said Thursday it will change its name to ACCESS Newswire and trade under the new ticker ACCS on the NYSE American Exchange, effective Jan. 27. No action is required by stockholders with respect to the changes, the company said. Price: 9.00, Change: +0.14, Percent Change: +1.58 ...
Citigroup cuts more jobs to meet expense goals, Bloomberg News reports
Citigroup cuts more jobs to meet expense goals, Bloomberg News reports
Jan 16, 2025
(Reuters) -Citigroup ( C/PN ) is cutting more jobs this week to meet CEO Jane Fraser's expense goals, Bloomberg News reported on Thursday, citing people familiar with the matter.  Managing directors in the wealth and technology units are leaving the firm and Citi is also axing people from a team that compiles data and analysis on the bank's clients, according...
Copyright 2023-2026 - www.financetom.com All Rights Reserved